 |
9 Diseases |  |
1 Trial |
|
1 Trial |  |
1 News |  |
- 4SCAR30273 / University of South Florida, Peking Union Medical College
New P1/2 trial, CAR T-Cell Therapy: CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273) (clinicaltrials.gov) - Oct 24, 2014
P1/2, N=20, Recruiting, Sponsor: Peking University